undefined undefined
NaN.000
NaN.00%
Piper Sandler analyst Matt O'Brien maintains Penumbra (NYSE:PEN) with a Overweight and lowers the price target from $290 to $260.
05-09 00:06
In the latest quarter, 7 analysts provided ratings for Penumbra (NYSE:PEN), sho...
05-08 22:00
Needham analyst Mike Matson reiterates Penumbra (NYSE:PEN) with a Hold.
05-08 20:20
Unity Software(U.US) reported fourth-quarter financial results after the market...
05-08 20:20
ALAMEDA, Calif., May 7, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter e...
05-08 04:05
Penumbra (NYSE:PEN) is scheduled to announce Q1 earnings results on Tuesday, May 7th, after market close. The consensus EPS Estimate is $0.38 (+65.2% Y/Y) and the consensus Revenue Estimate is $274.5M...
05-07 05:35
ALAMEDA, Calif., May 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today a...
05-02 04:05
It hasn't been the best quarter for Penumbra, Inc. (NYSE:PEN) shareholders, sin...
04-26 21:04